qXR-CTR vs Study Watch with Irregular Pulse Monitor (Home)
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary need is to efficiently and consistently automate the measurement of cardiothoracic ratio from existing chest X-ray images. This tool is ideal for radiology departments and cardiology practices seeking to streamline the initial assessment of heart size and identify potential heart failure risk from routine imaging studies.
View qXR-CTR →Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose the Verily Study Watch if you require continuous, long-term, and unobtrusive physiological data collection from patients in a home setting, especially for detecting intermittent cardiac events like atrial fibrillation. This wearable is best suited for clinical research or remote patient monitoring programs where detailed, real-world physiological insights are crucial for diagnosis and management.
View Study Watch with Irregular Pulse Monitor (Home) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Unknown |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRTool A, qXR-CTR, is an AI-powered software designed to integrate into existing radiology workflows, automating a specific measurement task. This typically offers a more streamlined and controlled user experience for healthcare providers compared to Tool B, which is a wearable device requiring patient compliance and active management by clinicians for data collection and device upkeep.
Clinical Value
Study Watch with Irregular Pulse Monitor (Home)While Tool A provides a valuable quantitative metric for heart failure risk, Tool B, the Study Watch, offers continuous, multi-parameter physiological monitoring with a direct focus on detecting atrial fibrillation, a prevalent and serious condition. The ability to detect AFib early through unobtrusive, long-term monitoring offers significant potential for improved patient outcomes and proactive management.
Pricing & Value
TieBoth tools require direct contact for pricing information, with details not publicly disclosed. Without specific financial data for either product, it is impossible to conduct a head-to-head comparison of their value propositions or determine which offers better value.
Enterprise Readiness
qXR-CTRTool A offers flexible deployment options (cloud, on-premise, hybrid) and explicitly states HIPAA compliance and BAA without reported issues, which are crucial for enterprise adoption. Tool B, despite its FDA clearance and BAA, has a reported lawsuit alleging past HIPAA breaches, which could pose a significant risk for enterprise customers. The wearable deployment model also introduces additional logistical complexities for large-scale enterprise management.
Innovation
Study Watch with Irregular Pulse Monitor (Home)Tool B demonstrates greater innovation by integrating multiple advanced physiological and environmental sensors into a prescription-only wearable for continuous, unobtrusive data collection and AFib detection. This comprehensive approach to remote patient monitoring, coupled with its focus on clinical research and healthcare use, represents a more novel and sophisticated application of AI and sensor technology compared to Tool A's specific automation of a known measurement.
Support & Docs
qXR-CTRQure.ai provides a 'Qure.ai App User's Manual' for installation, features, and configuration with medical systems, along with 'Gateway User Manual' and 'Platform API' documentation, which are crucial for seamless enterprise integration and ongoing management. The mention of multilingual support further enhances its enterprise readiness for diverse environments. While Verily also offers documentation and support resources, Qure.ai's explicit detailing of integration-focused documentation gives it a slight edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Name | qXR-CTR | Study Watch with Irregular Pulse Monitor (Home) |
| Company | Qure.ai Technologies | Verily Life Sciences LLC |
| Description | qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics. |
| Tagline | AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. | Making health data useful for healthier, more vibrant lives. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and Study Watch with Irregular Pulse Monitor (Home).